Voyager Therapeutics, Inc. Operating Expenses
Voyager Therapeutics, Inc. (VYGR) reported Operating Expenses of $29.56 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-06
- Voyager Therapeutics, Inc. operating expenses for the quarter ending 2026-06-30 was $29.56M, a 29.33% decline year-over-year.
- Voyager Therapeutics, Inc. operating expenses for the quarter ending 2026-03-31 was $32.86M, a 20.17% decline year-over-year.
- Voyager Therapeutics, Inc. operating expenses for the quarter ending 2025-12-31 was $45.27M, a 1.55% increase year-over-year.
- Voyager Therapeutics, Inc. operating expenses for the quarter ending 2025-09-30 was $43.96M, a 14.45% increase year-over-year.
- Voyager Therapeutics, Inc. operating expenses for fiscal 2025 was $172.22M, a 5.47% increase from fiscal 2024.
- Voyager Therapeutics, Inc. operating expenses for fiscal 2024 was $163.29M, a 27.57% increase from fiscal 2023.
- Voyager Therapeutics, Inc. operating expenses for fiscal 2023 was $127.99M, a 39.51% increase from fiscal 2022.
- Voyager Therapeutics, Inc. operating expenses for fiscal 2022 was $91.74M, a 17.37% decline from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $29.56M 10-Q · filed 2026-08-06 | $62.42M 10-Q · filed 2026-08-06 | $107.69M derived: sum of 3 quarters · filed 2026-08-06 | $151.65M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $32.86M 10-Q · filed 2026-05-07 | $78.13M derived: sum of 2 quarters · filed 2026-05-07 | $122.09M derived: sum of 3 quarters · filed 2026-05-07 | $163.91M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $45.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $89.23M derived: sum of 2 quarters · filed 2026-03-09 | $131.05M derived: sum of 3 quarters · filed 2026-08-06 | $172.22M 10-K · filed 2026-03-09 |
| 2025-09-30 | $43.96M 10-Q · filed 2025-11-10 | $85.78M derived: sum of 2 quarters · filed 2026-08-06 | $126.95M 10-Q · filed 2025-11-10 | $171.53M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $41.83M 10-Q · filed 2026-08-06 | $82.99M 10-Q · filed 2026-08-06 | $127.57M derived: sum of 3 quarters · filed 2026-08-06 | $165.98M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $41.17M 10-Q · filed 2026-05-07 | $85.74M derived: sum of 2 quarters · filed 2026-05-07 | $124.15M derived: sum of 3 quarters · filed 2026-05-07 | $168.75M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $44.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $82.99M derived: sum of 2 quarters · filed 2026-03-09 | $127.59M derived: sum of 3 quarters · filed 2026-03-09 | $163.29M 10-K · filed 2026-03-09 |
| 2024-09-30 | $38.41M 10-Q · filed 2025-11-10 | $83.01M derived: sum of 2 quarters · filed 2025-11-10 | $118.71M 10-Q · filed 2025-11-10 | $154.71M derived: sum of 4 quarters · filed 2026-03-09 |
| 2024-06-30 | $44.60M 10-Q · filed 2025-08-06 | $80.30M 10-Q · filed 2025-08-06 | $116.30M derived: sum of 3 quarters · filed 2026-03-09 | $150.42M derived: sum of 4 quarters · filed 2026-03-09 |
| 2024-03-31 | $35.70M 10-Q · filed 2025-05-06 | $71.70M derived: sum of 2 quarters · filed 2026-03-09 | $105.82M derived: sum of 3 quarters · filed 2026-03-09 | $136.10M derived: sum of 4 quarters · filed 2026-03-09 |
| 2023-12-31 | $36.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $70.12M derived: sum of 2 quarters · filed 2026-03-09 | $100.40M derived: sum of 3 quarters · filed 2026-03-09 | $127.99M 10-K · filed 2026-03-09 |
| 2023-09-30 | $34.12M 10-Q · filed 2024-11-12 | $64.40M derived: sum of 2 quarters · filed 2024-11-12 | $92.00M 10-Q · filed 2024-11-12 | $115.01M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-06-30 | $30.28M 10-Q · filed 2024-08-06 | $57.88M 10-Q · filed 2024-08-06 | $80.89M derived: sum of 3 quarters · filed 2025-03-11 | $107.53M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-03-31 | $27.60M 10-Q · filed 2024-05-13 | $50.61M derived: sum of 2 quarters · filed 2025-03-11 | $77.25M derived: sum of 3 quarters · filed 2025-03-11 | $97.33M derived: sum of 4 quarters · filed 2025-03-11 |
| 2022-12-31 | $23.01M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $49.66M derived: sum of 2 quarters · filed 2025-03-11 | $69.74M derived: sum of 3 quarters · filed 2025-03-11 | $91.74M 10-K · filed 2025-03-11 |
| 2022-09-30 | $26.64M 10-Q · filed 2023-11-06 | $46.72M derived: sum of 2 quarters · filed 2023-11-06 | $68.73M 10-Q · filed 2023-11-06 | $91.10M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $20.08M 10-Q · filed 2023-08-03 | $42.09M 10-Q · filed 2023-08-03 | $64.46M derived: sum of 3 quarters · filed 2024-02-28 | $91.09M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $22.01M 10-Q · filed 2023-05-09 | $44.38M derived: sum of 2 quarters · filed 2024-02-28 | $71.01M derived: sum of 3 quarters · filed 2024-02-28 | $100.95M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $22.37M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $49.00M derived: sum of 2 quarters · filed 2024-02-28 | $78.94M derived: sum of 3 quarters · filed 2024-02-28 | $111.03M 10-K · filed 2024-02-28 |
| 2021-09-30 | $26.63M 10-Q · filed 2022-11-08 | $56.57M derived: sum of 2 quarters · filed 2022-11-08 | $88.66M 10-Q · filed 2022-11-08 | $118.93M derived: sum of 4 quarters · filed 2023-03-07 |
| 2021-06-30 | $29.94M 10-Q · filed 2022-08-04 | $62.03M 10-Q · filed 2022-08-04 | $92.30M derived: sum of 3 quarters · filed 2023-03-07 | $125.61M derived: sum of 4 quarters · filed 2023-03-07 |
| 2021-03-31 | $32.09M 10-Q · filed 2022-05-04 | $62.36M derived: sum of 2 quarters · filed 2023-03-07 | $95.67M derived: sum of 3 quarters · filed 2023-03-07 | $133.33M derived: sum of 4 quarters · filed 2023-03-07 |
| 2020-12-31 | $30.27M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $63.58M derived: sum of 2 quarters · filed 2023-03-07 | $101.24M derived: sum of 3 quarters · filed 2023-03-07 | $143.74M 10-K · filed 2023-03-07 |
| 2020-09-30 | $33.32M 10-Q · filed 2021-11-02 | $70.98M derived: sum of 2 quarters · filed 2021-11-02 | $113.48M 10-Q · filed 2021-11-02 | $159.92M derived: sum of 4 quarters · filed 2021-11-02 |
| 2020-06-30 | $37.66M 10-Q · filed 2021-08-09 | $80.16M 10-Q · filed 2021-08-09 | $126.60M derived: sum of 3 quarters · filed 2021-08-09 | $164.84M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | $42.50M 10-Q · filed 2021-05-10 | $88.94M derived: sum of 2 quarters · filed 2021-05-10 | $127.18M derived: sum of 3 quarters · filed 2021-05-10 | $164.08M derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | $46.44M 10-K · filed 2020-03-03 | $84.68M derived: sum of 2 quarters · filed 2020-11-09 | $121.58M derived: sum of 3 quarters · filed 2020-11-09 | $156.07M 10-K · filed 2022-03-08 |
| 2019-09-30 | $38.24M 10-Q · filed 2020-11-09 | $75.14M derived: sum of 2 quarters · filed 2020-11-09 | $109.63M 10-Q · filed 2020-11-09 | $134.80M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $36.90M 10-Q · filed 2020-08-10 | $71.39M 10-Q · filed 2020-08-10 | $96.56M derived: sum of 3 quarters · filed 2020-08-10 | $119.80M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $34.49M 10-Q · filed 2020-05-06 | $59.66M derived: sum of 2 quarters · filed 2020-05-06 | $82.90M derived: sum of 3 quarters · filed 2020-05-06 | $111.17M derived: sum of 4 quarters · filed 2020-05-06 |
| 2018-12-31 | $25.17M 10-K · filed 2020-03-03 | $48.41M derived: sum of 2 quarters · filed 2020-03-03 | $76.68M derived: sum of 3 quarters · filed 2020-03-03 | $98.71M 10-K · filed 2021-02-25 |
| 2018-09-30 | $23.24M 10-K · filed 2020-03-03 | $51.51M derived: sum of 2 quarters · filed 2020-03-03 | $73.55M 10-Q · filed 2019-11-06 | $92.24M derived: sum of 4 quarters · filed 2020-03-03 |
| 2018-06-30 | $28.27M 10-K · filed 2020-03-03 | $50.30M 10-Q · filed 2019-08-09 | $69.00M derived: sum of 3 quarters · filed 2020-03-03 | $93.50M derived: sum of 4 quarters · filed 2020-03-03 |
| 2018-03-31 | $22.04M 10-K · filed 2020-03-03 | $40.73M derived: sum of 2 quarters · filed 2020-03-03 | $65.23M derived: sum of 3 quarters · filed 2020-03-03 | $85.05M derived: sum of 4 quarters · filed 2020-03-03 |
| 2017-12-31 | $18.69M 10-K · filed 2019-02-26 | $43.20M derived: sum of 2 quarters · filed 2019-02-26 | $63.01M derived: sum of 3 quarters · filed 2019-02-26 | $82.00M 10-K · filed 2020-03-03 |
| 2017-09-30 | $24.50M 10-K · filed 2019-02-26 | $44.32M derived: sum of 2 quarters · filed 2019-02-26 | $63.30M 10-Q · filed 2018-11-07 | $79.51M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $19.82M 10-K · filed 2019-02-26 | $38.80M 10-Q · filed 2018-08-07 | $55.01M derived: sum of 3 quarters · filed 2019-02-26 | $68.69M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $18.99M 10-K · filed 2019-02-26 | $35.19M derived: sum of 2 quarters · filed 2019-02-26 | $48.87M derived: sum of 3 quarters · filed 2019-02-26 | $62.21M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $16.20M 10-K · filed 2018-03-14 | $29.88M derived: sum of 2 quarters · filed 2018-03-14 | $43.22M derived: sum of 3 quarters · filed 2018-03-14 | $55.52M 10-K · filed 2019-02-26 |
| 2016-09-30 | $13.68M 10-K · filed 2018-03-14 | $27.02M derived: sum of 2 quarters · filed 2018-03-14 | $39.31M 10-Q · filed 2017-11-02 | $51.69M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-06-30 | $13.34M 10-K · filed 2018-03-14 | $25.64M 10-Q · filed 2017-08-08 | $38.01M derived: sum of 3 quarters · filed 2018-03-14 | $46.97M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-03-31 | $12.30M 10-K · filed 2018-03-14 | $24.67M derived: sum of 2 quarters · filed 2018-03-14 | $33.63M derived: sum of 3 quarters · filed 2018-03-14 | $42.48M derived: sum of 4 quarters · filed 2018-03-14 |
| 2015-12-31 | $12.38M 10-K · filed 2017-03-15 | $21.33M derived: sum of 2 quarters · filed 2017-03-15 | $30.18M derived: sum of 3 quarters · filed 2017-03-15 | $37.59M 10-K · filed 2018-03-14 |
| 2015-09-30 | $8.96M 10-K · filed 2017-03-15 | $17.81M derived: sum of 2 quarters · filed 2017-03-15 | $25.21M 10-Q · filed 2016-11-10 | $29.71M derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-06-30 | $8.85M 10-K · filed 2017-03-15 | $16.25M 10-Q · filed 2016-08-11 | $20.75M derived: sum of 3 quarters · filed 2017-03-15 | $24.41M derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-03-31 | $7.40M 10-K · filed 2017-03-15 | $11.90M derived: sum of 2 quarters · filed 2017-03-15 | $15.56M derived: sum of 3 quarters · filed 2017-03-15 | $18.79M derived: sum of 4 quarters · filed 2017-03-15 |
| 2014-12-31 | $4.50M 10-K · filed 2016-03-17 | $8.15M derived: sum of 2 quarters · filed 2016-03-17 | $11.38M derived: sum of 3 quarters · filed 2016-03-17 | $14.37M 10-K · filed 2017-03-15 |
| 2014-09-30 | $3.66M 10-K · filed 2016-03-17 | $6.89M derived: sum of 2 quarters · filed 2016-03-17 | $9.87M 10-Q · filed 2015-12-17 | |
| 2014-06-30 | $3.23M 10-K · filed 2016-03-17 | $6.21M derived: sum of 2 quarters · filed 2016-03-17 | ||
| 2014-03-31 | $2.98M 10-K · filed 2016-03-17 | |||
| 2013-12-31 | $3.77M 10-K · filed 2016-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |